"HIV Vaccine Efficacy Trial Preparedness: Key Factors Among Out of Treatment Injection Drug Users."

According to an abstract submitted by the authors to the 11th International Conference on AIDS, held July 7-12, 1996, in Vancouver, British Columbia, "Issue: Future HIV vaccine efficacy trials will require the inclusion of thousands of people, ideally including a cross-representation of the populations at greatest risk of acquiring HIV infection. The out of treatment injection drug using population is one such group that will be important to include if efficacy trials are to be able to generalize results to this important at-risk population. Project: A vaccine interest questionnaire (VIQ) was administered to 953 out of treatment IDUs by experienced street outreach staff...

Want to see the full article?

• Purchase this article for only $3.00